Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy. - Wikidata - awgldk - TriplyDB

Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.

Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.

http://www.wikidata.org/entity/Q34623738

about

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation The Science behind the Probiotic Strain Bifidobacterium animalis subsp. lactis BB-12(®)Impact of orally administered lozenges with Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp. lactis BB-12 on the number of salivary mutans streptococci, amount of plaque, gingival inflammation and the oral microbiome in healthy adults Association between funding source, methodological quality and research outcomes in randomized controlled trials of synbiotics, probiotics and prebiotics added to infant formula: a systematic review.Severe viral respiratory infections: are bugs bugging?Advantageous direct quantification of viable closely related probiotics in petit-suisse cheeses under in vitro gastrointestinal conditions by Propidium Monoazide--qPCR.Probiotic actions on diseases: implications for therapeutic treatments.Combinational effects of prebiotic oligosaccharides on bifidobacterial growth and host gene expression in a simplified mixed culture model and neonatal mice.Probiotics for prevention and treatment of respiratory tract infections in children: A systematic review and meta-analysis of randomized controlled trials Enzymatically-Processed Wheat Bran Enhances Macrophage Activity and Has in Vivo Anti-Inflammatory Effects in Mice.Haemophilus haemolyticus Interaction with Host Cells Is Different to Nontypeable Haemophilus influenzae and Prevents NTHi Association with Epithelial Cells Effect of Bifidobacterium animalis ssp. lactis GCL2505 on visceral fat accumulation in healthy Japanese adults: a randomized controlled trial.Clinical detection of human probiotics and human pathogenic bacteria by using a novel high-throughput platform based on next generation sequencing.The Influence of the Microbiome on Early-Life Severe Viral Lower Respiratory Infections and Asthma-Food for Thought?Otitis media among high-risk populations: can probiotics inhibit Streptococcus pneumoniae colonisation and the risk of disease?Panel 1: Epidemiology, natural history, and risk factors.Probiotics and prebiotics in infants and children.The role of probiotics and prebiotics in inducing gut immunity.Probiotics in respiratory virus infections.Probiotics for the prevention of pediatric upper respiratory tract infections: a systematic review.Safety and efficacy of human breast milk Lactobacillus fermentum CECT 5716. A mini-review of studies with infant formulae.Use of probiotics in pediatric infectious diseases.Probiotic Formulations: Application and Status as Pharmaceuticals-A Review.Network meta-analysis of probiotics to prevent respiratory infections in children and adolescents.Probiotic and synbiotic safety in infants under two years of age.Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in early childhood.A single mutation in the gene responsible for the mucoid phenotype of Bifidobacterium animalis subsp. lactis confers surface and functional characteristics.Consumption of Bifidobacterium animalis subsp. lactis BB-12 impacts upper respiratory tract infection and the function of NK and T cells in healthy adults.Role of short-term use of L. acidophilus DDS-1 and B. lactis UABLA-12 in acute respiratory infections in children: a randomized controlled trial.Daily intake of fermented milk with Lactobacillus casei strain Shirota reduces the incidence and duration of upper respiratory tract infections in healthy middle-aged office workers.Selection of a Bifidobacterium animalis subsp. lactis strain with a decreased ability to produce acetic acid Effect of Lactobacillus rhamnosus LGG® and Bifidobacterium animalis ssp. lactis BB-12® on health-related quality of life in college students affected by upper respiratory infections.The First Microbial Colonizers of the Human Gut: Composition, Activities, and Health Implications of the Infant Gut Microbiota.A prebiotic mixture improved Lactobacillus acidophilus and Bifidobacterium animalis gastrointestinal in vitro resistance in petit-suisse.A microbiome case-control study of recurrent acute otitis media identified potentially protective bacterial genera.Study to investigate the potential of probiotics in children attending school.Probiotic Bifidobacterium strains and galactooligosaccharides improve intestinal barrier function in obese adults but show no synergism when used together as synbiotics.

P2860

Q26748672-DE3438D8-59A3-4653-9F3C-722CA3C885B4 Q28829661-558809B8-CDCB-4683-8A4A-EE6435EEBE89 Q34863656-2A15E327-63F6-4193-8403-B789579ED5EA Q35039235-518409A8-8814-4278-8B94-ABE637BFA1C5 Q35039520-54D0E1A1-2508-4BAF-A6D8-4BC75F8B81BC Q35072607-6948C65A-A07F-431C-B213-A45B06552314 Q35096915-7FCDA9C8-58B0-4696-A333-348D3B516CD5 Q36023124-1068F07C-DCA4-4B78-BA36-28B218030BD9 Q36096223-B0B806B6-0D1B-42B7-A603-E757C1ABA27F Q36846204-B904309D-BA10-412C-B7DD-C700761337D1 Q36881633-96BE6A96-2923-4684-AB12-432C6C6A60E6 Q37411378-7ADA1300-A9FF-4A4D-924C-967AFE667342 Q37514648-0B097553-54E3-4274-8EBB-8A1507745CD5 Q37643936-448A5983-F11D-43F8-BA0F-DC12FC8A031A Q38091357-7BCC6132-1631-4D78-B510-191630B1F678 Q38093819-9556212A-236B-4A79-AC75-09D9DD005AC9 Q38103761-7E8FE9AE-6A30-4393-B4DF-15EB62427DE6 Q38174603-F0BDC40F-8EFB-46CF-A664-CF8BFB4121CE Q38196730-FA22353C-04B2-4896-8CD1-1828FC4D792E Q38272153-A461A5FD-DFED-405B-A618-A52D464B1E1A Q38292255-2E597DC0-FE7E-4E2D-B901-4B7BDA4231FF Q38614997-B2F778EF-B409-4D22-A99A-7261DECEA707 Q38702214-842F1DF8-5263-48A4-BCC8-0B33B1F9291B Q39067292-4EBA71D6-5687-4CBA-935C-35BA44ACE2C2 Q39264265-CE524396-84A7-45A6-849D-16AA21688BD2 Q40139300-9C72F44D-A1F8-4B5F-AB97-5BA813AFFD6C Q40546936-CC68EA7B-8166-4FF1-A7FF-F7D29429BFAF Q40814225-68AEE527-103C-469B-AE36-12B867A73D81 Q40954271-3A79A8A7-E4BA-4242-BCDC-15C9AF0F156B Q40975107-6C57E505-11D9-4D51-A448-13F15F008047 Q42119942-649BC843-726E-4014-9849-D1DAB1AD4562 Q44785206-5A69B93B-539D-4E1A-95AC-B3B705E53623 Q46265536-3DBA8E0B-EFD4-4635-83CE-8E3E90E549C5 Q46558346-1C26A764-E5E4-49D1-9BD8-DDC72985AE05 Q49843935-07803557-E2E0-408B-8641-A38DDF8D132E Q51056127-4EC98983-7478-4416-8742-722AAA5FF95E Q55514036-C0664D94-DFDA-4CE3-A2BA-125ADDE1DA72

P2860

Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.

http://www.wikidata.org/entity/Q34623738

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@ast

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@en

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@nl

type

label

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@ast

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@en

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@nl

prefLabel

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@ast

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@en

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@nl

P1433

Q34623738-E00E5353-590D-4FF4-8411-AEFEE2AD62FA

P1476

Q34623738-95C8DC78-72FA-4286-B433-C8B37AB3240D

P2093

Q34623738-079308FC-E851-4C7A-A4D4-736443B3835E

Q34623738-0FCC8507-EB99-43ED-9CF9-8972251CCE14

Q34623738-302F3971-8A7E-4BD3-A5C8-4C52E3DDFD97

Q34623738-42339E20-3526-482B-BAEA-2A91FA22AA12

Q34623738-57CD27C0-AE11-440D-B604-C73C20F95A02

Q34623738-72F43FD1-C54E-4E0E-96AF-472AC64CF01B

Q34623738-9527E2BF-AB0A-405B-B540-23140141BCD9

Q34623738-CC63D4A4-AD85-4621-B767-2DA38841A373

P2860

Q34623738-04770418-E140-46C3-BC69-54A68092D7C8

Q34623738-1449CB7F-50B5-416D-AF8E-7343A37C3E06

Q34623738-271B142A-4F3E-4128-A837-B0F87164AE6B

Q34623738-2C68564E-1001-4C1D-A827-6CAD57D9E044

Q34623738-3575AEA1-B6E8-4B84-BD74-60131CD4EE91

Q34623738-455ADC8C-0760-4CF3-A7A8-52FDDA2942A2

Q34623738-4AF5299E-93FA-4E77-AAE4-56B0939AB57B

Q34623738-4BB9A1E4-70F7-4122-94E3-C88E20C039CE

Q34623738-4CEF4543-7503-467C-889A-D4DFD84ECCC4

Q34623738-4F973E90-73C9-4B6F-B58E-F2E270EBF9ED

P304

Q34623738-A78C2303-DDE0-44A4-921C-DA8EB7C91937

P31

Q34623738-88DDF289-9F8A-4265-801A-165489979775

P356

Q34623738-32DD70D3-F3D6-4F12-B38B-1F52B7B59515

P433

Q34623738-4F55F110-BEDE-452A-B520-67D0E60307DD

P478

Q34623738-9FBE5E84-94E8-4FD3-AF28-48060425CD20

P577

Q34623738-B91F83EB-3D9F-4208-AD1A-B9F997E7E6EF

P698

Q34623738-CB122232-0004-4564-BD9C-042923D33F4D

P356

S0007114510003685

P1433

British Journal of Nutrition

P1476

Bifidobacterium animalis subsp ...... risk of infections in infancy.

@en

P2093

Charlotte Larsen

http://www.w3.org/2001/XMLSchema#string

Elke Brockmann

http://www.w3.org/2001/XMLSchema#string

Erika Isolauri

http://www.w3.org/2001/XMLSchema#string

Eva Söderling

http://www.w3.org/2001/XMLSchema#string

Jorma Jokela

http://www.w3.org/2001/XMLSchema#string

Kaisu Pienihäkkinen

http://www.w3.org/2001/XMLSchema#string

Pentti Alanen

http://www.w3.org/2001/XMLSchema#string

Teemu Taipale

http://www.w3.org/2001/XMLSchema#string

P2860

Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.

Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods.

Recommendations for probiotic use--2008.

The development of the immune system during pregnancy and early life.

Probiotics in the treatment and prevention of acute infectious diarrhea in infants and children: a systematic review of published randomized, double-blind, placebo-controlled trials.

Role of probiotics in food hypersensitivity.

Potential uses of probiotics in the neonate.

Probiotics in intestinal and non-intestinal infectious diseases--clinical evidence.

Modulation of the maturing gut barrier and microbiota: a novel target in allergic disease.

Probiotic effects on cold and influenza-like symptom incidence and duration in children.

P304

409-416

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1017/S0007114510003685

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

105

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20863419

http://www.w3.org/2001/XMLSchema#string